Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain

European Journal of Pain : EJP
Albert DahanElise Sarton

Abstract

Pharmacological treatment of chronic (neuropathic) pain is often disappointing. In order to enhance our insight in the complex interaction between analgesic drug and chronic pain relief, we performed a pharmacokinetic-pharmacodynamic (PK-PD) modeling study on the effect of S(+)-ketamine on pain scores in Complex Regional Pain Syndrome type 1 (CRPS-1) patients. Sixty CRPS-1 patients were randomly allocated to received a 100-h infusion of S(+)-ketamine or placebo. The drug infusion rate was slowly increased from 5 mg/h (per 70 kg) to 20 mg/h based upon the effect/side effect profile. Pain scores and drug blood samples were obtained during the treatment phase and pain scores were further obtained weekly for another 11 weeks. A population PK-PD model was developed to analyze the S(+)-ketamine-pain data. Plasma concentrations of S(+)-ketamine and its metabolite decreased rapidly upon the termination of S(+)-ketamine infusion. The chance for an analgesic effect from ketamine and placebo treatment was 67±10% and 23±9% (population value±SE), respectively. The pain data were well described by the PK-PD model with parameters C(50)=10.5±4.8 ng/ml (95% ci 4.37-21.2 ng/ml) and t½ for onset/offset=10.9±4.0 days (5.3-20.5 days). Long-term S(+...Continue Reading

References

Feb 1, 1992·Journal of Pharmacokinetics and Biopharmaceutics·J R VarvelS L Shafer
Dec 1, 1987·British Journal of Haematology·A WallmarkI M Nilsson
Jun 1, 1987·Journal of Pharmacokinetics and Biopharmaceutics·J SchüttlerL B Sheiner
May 1, 1996·Clinical Pharmacokinetics·N H Holford
Sep 9, 2000·The New England Journal of Medicine·R J Schwartzman
Jun 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Youssef Hijazi, Roselyne Boulieu
Aug 9, 2007·Paediatric Anaesthesia·David W HerdNicholas H G Holford
Mar 19, 2008·Annals of Vascular Surgery·Raneem AlbazazShervanthi Homer-Vanniasinkam
Mar 21, 2008·Trends in Pharmacological Sciences·Meindert DanhofRob A Voskuyl
Mar 5, 2009·Nature Reviews. Neuroscience·Jeffrey S Mogil
Jul 4, 2009·Pain·David Borsook
Jul 21, 2009·Pharmacology & Therapeutics·Jörn LötschIrmgard Tegeder
Nov 20, 2009·Current Rheumatology Reports·Candida S McCabeNigel Harris

❮ Previous
Next ❯

Citations

Dec 1, 2012·Journal of Pharmacokinetics and Pharmacodynamics·Ashraf YassenAlbert Dahan
Feb 3, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·R Norman Harden
Aug 9, 2012·Expert Opinion on Drug Metabolism & Toxicology·Marieke Niesters, Albert Dahan
Jan 17, 2014·Expert Opinion on Drug Metabolism & Toxicology·Haitao YangXu Steven Xu
Jan 15, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Sara B ConnollyR Norman Harden
Dec 24, 2015·Frontiers in Psychiatry·Charles F ZorumskiCharles R Conway
May 5, 2012·British Journal of Clinical Pharmacology·Asbjørn M DrewesAlbert Dahan
Feb 26, 2013·British Journal of Clinical Pharmacology·Marieke NiestersAlbert Dahan
Mar 31, 2016·Clinical Pharmacokinetics·Marko A PeltoniemiTeijo I Saari
Jul 23, 2015·British Journal of Anaesthesia·T T DongA W Gelb
Jun 15, 2015·The Journal of Pain : Official Journal of the American Pain Society·Sabrina R DouglasSeena K Ajit
Mar 1, 2015·European Journal of Clinical Pharmacology·Samuel FantaEija Kalso
May 10, 2016·Journal of Pain & Palliative Care Pharmacotherapy·Daryl S HenshawJonathan D Jaffe
Mar 14, 2018·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Jijun XuR Norm Harden
Jun 22, 2018·The Clinical Journal of Pain·Lisa V Doan, Jing Wang
Oct 6, 2017·F1000Research·Kelly JonkmanMonique van Velzen
Jan 22, 2019·Expert Review of Clinical Pharmacology·Louise KuhlmannAsbjørn M Drewes
May 5, 2011·Expert Review of Neurotherapeutics·Robert J SchwartzmanJohn R Grothusen
Nov 25, 2011·Expert Review of Clinical Pharmacology·Christian MartiniAlbert Dahan
Dec 21, 2017·Current Protocols in Pharmacology·Botros B ShenodaSeena K Ajit
Jan 29, 2020·Expert Review of Clinical Pharmacology·Yunpeng YangSteven P Cohen
Feb 20, 2016·Anesthesia and Analgesia·Jijun XuJianguo Cheng
Apr 14, 2012·Current Opinion in Supportive and Palliative Care·Paul R Nandi
Oct 1, 2020·Anesthesiology·Jasper KampUNKNOWN Ketamine Pharmacokinetic Study Group
Feb 6, 2020·Pharmacological Reports : PR·Julia Zaccarelli-MagalhãesHelenice de Souza Spinosa
Apr 21, 2020·Anesthesiology Research and Practice·Abby PribishArun Kalava
Feb 7, 2013·Human & Experimental Toxicology·Y KalkanA Turan
Feb 13, 2021·European Journal of Clinical Pharmacology·M E OttoMichiel J van Esdonk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.